Filter
2527
Filtered Results: 2527
Text search:
drug-resistance
infections
Featured
Recommendations
284
New Publications
656
Language
Document type
No document type
1397
Guidelines
407
Studies & Reports
395
Manuals
117
Strategic & Response Plan
92
Fact sheets
43
Training Material
42
Situation Updates
13
Infographics
10
Brochures
3
Resource Platforms
3
App
2
Online Courses
2
Videos
1
Countries / Regions
India
138
Global
75
South Africa
74
Kenya
71
Western and Central Europe
67
Ethiopia
56
Tanzania
44
Uganda
44
Africa
42
Eastern Europe
42
Nepal
41
Nigeria
37
Zambia
37
Latin America and the Carribbean
33
Namibia
32
Liberia
32
Malawi
30
Sierra Leone
29
Ghana
27
Rwanda
27
Bangladesh
25
Asia
24
Myanmar / Burma
24
Philippines
23
South–East Asia Region
22
Cambodia
20
Zimbabwe
18
Lesotho
17
Ukraine
16
Senegal
15
Russia
15
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
Botswana
10
Albania
8
Burkina Faso
8
West and Central Africa
8
Eswatini/ Swaziland
8
Thailand
7
Haiti
7
East and Southern Africa
7
Pakistan
7
Colombia
6
Syria
6
USA
6
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Argentina
6
China
5
Guinea
5
Georgia
5
Tajikistan
4
Benin
4
Iran
4
Germany
4
Western Pacific Region
4
Vietnam
4
Brazil
4
Sudan
4
North Macedonia
3
El Salvador
3
Laos
3
Peru
3
Jordan
3
North America
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Madagascar
2
Guatemala
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Greece
1
Angola
1
Chad
1
Libya
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
885
Clinical Guidelines
267
Public Health
97
Women & Child Health
77
Key Resources
64
Capacity Building
36
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
TB
447
HIV
332
AMR
318
NTDs
112
Malaria
86
COVID-19
81
Rapid Response
60
Mental Health
56
Pharmacy
53
Caregiver
45
Planetary Health
41
Ebola & Marburg
32
Refugee
27
Global Health Education
27
NCDs
20
Health Financing Toolbox
18
Polio
16
Conflict
13
Cholera
12
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte...
L’Assemblée mondiale de la Santé, tenue en mai 2015, a adopté un Plan d’action mondial pour combattre la résistance aux antimicrobiens, qui définit 5 objectifs:
mieux faire connaître et comprendre le problème de la résistance aux antimicrobiens grâce à une communication, une éduc...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
AMR is a serious and growing global problem. A WHO report released in 2014 stated that this serious threat is no longer a prediction for the future it is happening now in every region of the world and has potential to affect anyone, of any age in any community – a real threat to the public health....
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
Antimicrobial Resistance and Infection Control 2014,3 :31
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collection, transport, culture, anti-microbial drug suscept...
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
